Atrás
Pharmadrug Inc. (LMLLF) Ganando
Gráfico del Precio de Acciones LMLLF
LMLLF Ganando
Pharmadrug Inc.
$0
2.7%
$0
Al cierre: Mar 27, 16:00:00 GMT-4
$0
0%
$0
Mercado Posterior: Mar 27, 20:00:00 GMT-4
Earnings FAQ
¿Cómo se comparó el EPS reciente de LMLLF con las expectativas?
¿Cómo fue el desempeño de los ingresos de Pharmadrug Inc. LMLLF en el último trimestre?
¿Cuál es la estimación de ingresos para Pharmadrug Inc.?
¿Cuál es la puntuación de calidad de ganancias de Pharmadrug Inc.?
¿Cuándo informa Pharmadrug Inc. sus ganancias?
¿Cuáles son las ganancias esperadas de Pharmadrug Inc.?
¿Superó Pharmadrug Inc. las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$0.0074
Precio de apertura
$0.0076
Rango del día
$0.0076 - $0.0076
Rango de 52 semanas
$0.0022 - $0.0173
Volumen
12.0K
Volumen promedio
26.5K
Rendimiento de dividendos
--
EPS (TTM)
0.00
Cap. de mercado
$822.5K
¿Qué es PHARMADRUG INC.?
Pharmadrug, Inc. engages in the research, development, and commercialization of controlled substances and natural medicines such as psychedelics, cannabis and naturally derived approved drugs. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-08-16. The firm is focused on the research, development and commercialization of controlled substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third-party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The company also owns 100% of SecureDose Synthetics Inc. a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.